Latest News for: gsk
Edit
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) (Form 6-K) (GSK plc)
Public Technologies 17 Jun 2026
GSK plc ... GSK plc (LSE/NYSE ... About GSK ... [4] GSK press release, GSK and Spero Therapeutics announce exclusive licence agreement for tebipenem HBr, a late-stage antibiotic that may treat complicated urinary tract infections, 22 September 2022 ... GSK plc.
Edit
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) (GSK plc)
Public Technologies 17 Jun 2026
Edit
Annual Report of Employee Stock Purchase/Savings Plan (Form 11-K) (GSK plc)
Public Technologies 17 Jun 2026
Edit
Exdensur (depemokimab injection) approved in Canada for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps (GSK - GlaxoSmithKline Inc)
Public Technologies 16 Jun 2026
MISSISSAUGA, ONTARIO - GSK announced today that Health Canada has approved Exdensur (depemokimab) for two indications ... Michelle Horn, VP & Country Medical Director, GSK Canada, said ... About GSK in Respiratory ... About GSK ... Find out more at www.gsk.ca.
Edit
Ravalli Republic
13 Jun 2026
Darby School Board selects parent, GSK worker to fill vacancy
The Darby School board voted unanimously to select parent Alexander Olson to fill vacancy on the board during their Monday evening meeting ... .
Edit
GSK's momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome (Form 6-K) (GSK plc)
Public Technologies 12 Jun 2026
GSK plc ... GSK's momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome ... GSK plc (LSE/NYSE ... About GSK. GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
Edit
The Community Post
11 Jun 2026
Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK
Edit
Slaughter and May is advising GSK on its $10.6bn acquisition of Nuvalent (Slaughter and May (Operations) Ltd)
Public Technologies 11 Jun 2026
Slaughter and May is advising GSK plc ("GSK") on the UK aspects and financing of its acquisition of Nuvalent, Inc ... GSK is a global biopharmaceutical company with a purpose to unite science, ...
Edit
Transaction notification (Form 6-K) (GSK plc)
Public Technologies 11 Jun 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... CEO, ViiV Healthcare and President, Global Health, GSK ... GSK plc ... GSK plc ... GSK plc ... About GSK ... Find out more at www.gsk.com ... GSK plc ... behalf of GSK plc.
Edit
Caledonian Record
10 Jun 2026
The Franklin Institute and GSK Celebrate 40 Years of GSK Science in the Summer™ with ...
Edit
After shedding its cancer business just over a decade ago, GSK’s new CEO is building ...
Wall Street Journal 10 Jun 2026
Edit
GSK to Acquire U.S. Biotech Firm Nuvalent for $10.6bn in Largest Pharma Deal in... (Tekedia Capital LLC)
Public Technologies 10 Jun 2026
) GSK has agreed to acquire U.S ... [...]. This is an abstract of the document ... Attachments Original document Permalink. Disclaimer ... (noodl. 132394770) .
Edit
The Franklin Institute and GSK Celebrate 40 Years of GSK Science in the Summer™ with New "Be A Chemist!" Theme and Program Expansion
PR Newswire 10 Jun 2026
Students in grades 2 through 6 will become cosmetic, forensic, materials, medicinal, and water chemists as part of GSK Science in the Summer™, a free hands-on STEM enrichment program led by The Franklin Institute and supported by GSK.
- 1
- 2
- Next page »